Disclaimer

RS Research is a clinical-stage biotechnology company developing investigational programs using its proprietary Sagitta^® platform to enable targeted drug delivery and smart chemotherapy approaches designed to improve therapeutic benefit while minimizing side effects.

All research programs, pipeline candidates and related concepts described on this website or RS Research’s social media channels are investigational and have not been approved for general use by any regulatory authority.

The information provided is intended solely for general informational purposes for the scientific, clinical and business community. It does not constitute medical advice, does not replace consultation with qualified healthcare professionals and should not be used to diagnose, treat, cure, or prevent any disease.

References to clinical studies are provided for transparency and scientific context only and do not imply outcomes for any individual patient. Eligibility for participation in a clinical study can only be determined by the relevant study site and qualified investigators. Individuals should consult their physician or the study center for further information.

This website may contain forward-looking statements regarding research plans, development timelines, regulatory pathways and future expectations. Such statements are based on current assumptions and are subject to changes and uncertainties that may cause actual results to differ materially from those expressed or implied.

Nothing on this site or RS Research’s social media channels constitutes an offer to sell, or a solicitation of an offer to buy, any securities.

The content of this website is provided “as is” and may be updated or modified without prior notice. While RS Research endeavors to ensure the accuracy of the information presented, it makes no representations or warranties regarding completeness and shall not be liable for any direct or indirect damages arising from the use of this content.

RS Research is not responsible for the content of any third-party websites, including linked clinical trial registries or study sites.

All content on this website, including but not limited to text, graphics, logos, images, technical descriptions and designs, is the property of RS Research and is protected by applicable intellectual property and copyright laws. Unauthorized use, reproduction or distribution of any materials without prior written consent from RS Research is strictly prohibited.

For further information regarding our technology or research programs, please contact RS Research directly.